We have already described miR-181b and its target multiple apoptosis genes, such as BCL-2 and MCL-1. This miRNA was also associated to chronic lymphocytic leukemia and was shown to promote chemoresistance in pancreatic ductal adenocarcinoma cells and breast cancer [24]. This evidence concerns the gene BCL2 and breast cancer.